Just going to trials makes this a big MC stock. But if the results come out like is shown in the data, this will most likely get bought out. I know that is big talk but Biogen and Novartis are two big companies in the space. And trust me when I say someone will have an eye on this. I expect the float to increase with financing. But long term, this will at least a double digit dollar stock. Anyway, we still have a lot to go. Just a little of a brain wonder.